PBAKX
Price
$15.45
Change
+$0.07 (+0.46%)
Updated
Jun 6 closing price
Net Assets
3.05B
PCBSX
Price
$15.20
Change
+$0.06 (+0.40%)
Updated
Jun 6 closing price
Net Assets
3.05B
Interact to see
Advertisement

PBAKX vs PCBSX

Header iconPBAKX vs PCBSX Comparison
Open Charts PBAKX vs PCBSXBanner chart's image
BlackRock Tactical Opportunities K
Price$15.45
Change+$0.07 (+0.46%)
VolumeN/A
Net Assets3.05B
BlackRock Tactical Opportunities Service
Price$15.20
Change+$0.06 (+0.40%)
VolumeN/A
Net Assets3.05B
PBAKX vs PCBSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PBAKX vs. PCBSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBAKX is a Buy and PCBSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PBAKX (3.05B) and PCBSX (3.05B) have equal amount of cash in the bank . PBAKX (0.00) and PCBSX (0.00) have matching dividends . PBAKX was incepted earlier than PCBSX: PBAKX (9 years) vs PCBSX (20 years). PCBSX (1.09) is less costly to investors than PBAKX (0.69). PBAKX (146.00) and PCBSX (146.00) have comparable annual turnover. PCBSX has a lower initial minimum investment than PBAKX: PCBSX (5000) vs PBAKX (5000000). PBAKX annual gain was more profitable for investors over the last year : 9.34 vs. PCBSX (8.88). PBAKX return over 5 years is better than : 28.23 vs. PCBSX (25.82).
PBAKXPCBSXPBAKX / PCBSX
Total Expense Ratio0.691.0963%
Annual Report Gross Expense Ratio0.691.0963%
Fund Existence9 years20 years-
Gain YTD3.9703.754106%
Front LoadN/AN/A-
Min. Initial Investment50000005000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.05B3.05B100%
Annual Yield % from dividends0.000.00-
Returns for 1 year9.348.88105%
Returns for 3 years22.6421.30106%
Returns for 5 years28.2325.82109%
Returns for 10 yearsN/A30.94-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHSCX48.49N/A
N/A
BlackRock Health Sciences Opps Inv C
ECSMX10.95N/A
N/A
Eaton Vance Small-Cap C
MXVHX6.73N/A
N/A
Empower Large Cap Value Instl
HFECX53.09N/A
N/A
Janus Henderson European Focus C
TRIIX4.43N/A
N/A
Catalyst/SMH Total Return Income I